Skip to main content Accessibility help

Antimicrobial resistance patterns of urine culture specimens from 27 nursing homes: Impact of a two-year antimicrobial stewardship intervention

  • Meera Tandan (a1), Philip D. Sloane (a2) (a3), Kimberly Ward (a3), David J. Weber (a4) (a5), Akke Vellinga (a1) (a6), Christine E. Kistler (a2) (a3) and Sheryl Zimmerman (a3) (a7)...



Identify changes in the prevalence and antimicrobial resistance patterns of potentially pathogenic bacteria in urine cultures during a 2-year antimicrobial stewardship intervention program in nursing homes (NHs).


Before-and-after intervention study.


The study included 27 NHs in North Carolina.


We audited all urine cultures ordered before and during an antimicrobial stewardship intervention. Analyses compared culture rates, culture positive rates, and pathogen antimicrobial resistance patterns.


Of 6,718 total urine cultures collected, 68% were positive for potentially pathogenic bacteria. During the intervention, significant reductions in the urine culture and positive culture rates were observed (P = .014). Most of the identified potentially uropathogenic isolates were Escherichia coli (38%), Proteus spp (13%), and Klebsiella pneumoniae (12%). A significant decrease was observed during the intervention period in nitrofurantoin resistance among E. coli (P ≤ .001) and ciprofloxacin resistance among Proteus spp (P ≤ .001); however carbapenem resistance increased for Proteus spp (P ≤ .001). Multidrug resistance also increased for Proteus spp compared to the baseline. The high baseline resistance of E. coli to the commonly prescribed antimicrobials ciprofloxacin and trimethoprim-sulfamethoxazole (TMP/SMX) did not change during the intervention.


The antimicrobial stewardship intervention program significantly reduced urine culture and culture-positive rates. Overall, very high proportions of antimicrobial resistance were observed among common pathogens; however, antimicrobial resistance trended downward but reductions were too small and scattered to conclude that the intervention significantly changed antimicrobial resistance. Longer intervention periods may be needed to effect change in resistance patterns.


Corresponding author

Author for correspondence: Meera Tandan, Email:,


Hide All
1. Montoya, A, Mody, L. Common infections in nursing homes: a review of current issues and challenges. Aging Health 2011;7:889899.
2. Jones, AL, Dwyer, LL, Bercovitz, AR, Strahan, GW. The National Nursing Home Survey: 2004 overview. Vital Health Stat 13 2009;167:1155.
3. European Centre for Disease Prevention and Control. Point Prevalence Survey of Health Care-Associated Infections and Antimicrobial Use in European Long-Term Care Facilities. April–May 2013. Stockholm: ECDC; 2014.
4. Wagenlehner, F, Tandogdu, Z, Bartoletti, R, et al. the global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 2016;5:10.
5. Chopra, T, Goldstein, EJC. Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial stewardship. Clin Infect Dis 2015;60 suppl 2:S72S76.
6. Denkinger, CM, Grant, AD, Denkinger, M, Gautam, S, D’Agata, EM. Increased multi-drug resistance among the elderly on admission to the hospital—a 12-year surveillance study. Arch Gerontol Geriatr 2013;56:227230.
7. Sloane, PD, Kistler, CE, Reed, D, Weber, DJ, Ward, K, Zimmerman, S. Urine culture testing in community nursing homes: gateway to antibiotic overprescribing. Infect Control Hosp Epidemiol 2017;38:524531.
8. Cormican, M, Murphy, AW, Vellinga, A. Interpreting asymptomatic bacteriuria. BMJ 2011;343:d4780.
9. Phillips, CD, Adepoju, O, Stone, N, et al. Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr 2012;12:73.
10. Goossens, H, Ferech, M, Vander Stichele, R, Elseviers, M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579587.
11. Cek, M, Tandoğdu, Z, Wagenlehner, F, Tenke, P, Naber, K, Bjerklund-Johansen, TE. Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010. World J Urol 2014;32:15871594.
12. Horcajada, JP, Shaw, E, Padilla, B, et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 2013;19:962968.
13. Benoit, SR, Nsa, W, Richards, CL, et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008;56:20392044.
14. Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5):e103e120.
15. Gurwitz, JH, Field, TS, Avorn, J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:8794.
16. Tandan, M, Cormican, M, Vellinga, A. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials. Int J Antimicrob Agent 2018;52:529540.
17. Tanne, JH. FDA adds “black box” warning label to fluoroquinolone antibiotics. BMJ 2008;337(7662):135.
18. Clinical and Laboratory Standard Institute. Perfomance Standard for Antimicrobial Susceptability Testing—16th Informational Supplement. Wayne, PA: CLSI document M100-S18; 2008.
19. Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2015;34:114.
20. Magiorakos, AP, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268281.
21. Nursing home compare. Centers for Medicare and Medicaid Services website. Accessed July 27, 2018.
22. Gupta, K, Hooton, TM, Stamm, WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:4150.
23. Flores-Mireles, AL, Walker, JN, Caparon, M, Hultgren, SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Rev Microbiol 2015;13:269.
24. Rowe, TA, Juthani-Mehta, M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin N Am 2014;28:7589.
25. Florio, W, Tavanti, A, Barnini, S, Ghelardi, E, Lupetti, A. Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry. Front Microbiol 2018;9:1097.
26. Sloane, PD ZS, Ward, K, Kistler, KE, et al. Implementing antibiotic stewardship in community nursing homes: a two-year dissemination trial. Manuscript currently in review. 2018.
27. Elligsen, M, Walker, SAN, Pinto, R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2015;33:354361.
28. Dortch, MJ, Fleming, SB, Kauffmann, RM, Dossett, LA, Talbot, TR, May, AK. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect 2011;12:1525.
29. Jenkins, TC, Knepper, BC, Shihadeh, K, et al. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol 2015;36:664672.
30. del Arco, A, Tortajada, B, de la Torre, J, et al. The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance. Eur J Clin Microbiol Infect Dis 2015;34:247251.
31. Ikram, R, Psutka, R, Carter, A, Priest, P. An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors. BMC Infect Dis 2015;15:224.
32. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. US Food and Drug Administration website. Published 2016. Accessed July 4, 2018.
33. Goltsman, G, Mizrahi, EH, Leibovitz, A, Gal, G, Gorelik, O, Lubart, E. Comparative characteristic of antimicrobial resistance in geriatric hospital: a retrospective cohort study. Aging Clin Exper Res 2018;30:839843.
34. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 22nd Informational Supplement. Wayne, PA: CLSI; 2012.
35. Lutgring, JD, Limbago, BM. The problem of carbapenemase-producing carbapenem-resistant Enterobacteriaceae detection. J Clin Microbiol 2016;54:529534.
Type Description Title
Supplementary materials

Tandan et al. supplementary material
Tandan et al. supplementary material 1

 Word (18 KB)
18 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed